TNSN07225A1 - Metabolites of cyclosporin analogs - Google Patents
Metabolites of cyclosporin analogsInfo
- Publication number
- TNSN07225A1 TNSN07225A1 TNP2007000225A TNSN07225A TNSN07225A1 TN SN07225 A1 TNSN07225 A1 TN SN07225A1 TN P2007000225 A TNP2007000225 A TN P2007000225A TN SN07225 A TNSN07225 A TN SN07225A TN SN07225 A1 TNSN07225 A1 TN SN07225A1
- Authority
- TN
- Tunisia
- Prior art keywords
- metabolites
- isa247
- methods
- formation
- synthetic methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C07K7/645—Cyclosporins; Related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Transplantation (AREA)
- General Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63739204P | 2004-12-17 | 2004-12-17 | |
PCT/CA2005/001926 WO2006063470A1 (fr) | 2004-12-17 | 2005-12-19 | Metabolites d'analogues de la cyclosporine |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN07225A1 true TNSN07225A1 (en) | 2008-11-21 |
Family
ID=36587506
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNP2007000225A TNSN07225A1 (en) | 2004-12-17 | 2007-06-14 | Metabolites of cyclosporin analogs |
Country Status (14)
Country | Link |
---|---|
US (1) | US20060223743A1 (fr) |
EP (1) | EP1828229A4 (fr) |
JP (1) | JP2008524122A (fr) |
KR (1) | KR20070100284A (fr) |
CN (1) | CN101120012A (fr) |
AU (1) | AU2005316095A1 (fr) |
BR (1) | BRPI0517207A (fr) |
CA (1) | CA2592343A1 (fr) |
IL (1) | IL183908A0 (fr) |
MX (1) | MX2007007262A (fr) |
TN (1) | TNSN07225A1 (fr) |
TW (1) | TW200635954A (fr) |
WO (1) | WO2006063470A1 (fr) |
ZA (1) | ZA200705475B (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7696166B2 (en) | 2006-03-28 | 2010-04-13 | Albany Molecular Research, Inc. | Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders |
US7696165B2 (en) | 2006-03-28 | 2010-04-13 | Albany Molecular Research, Inc. | Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders |
ES2363452T3 (es) * | 2006-07-06 | 2011-08-04 | Ares Trading S.A. | Una composición farmacéutica oral de una anilinopirimidina, su preparación y uso de la misma. |
US20100094560A1 (en) * | 2006-08-15 | 2010-04-15 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
EP2151450A1 (fr) * | 2008-07-29 | 2010-02-10 | Sandoz AG | Procédé de préparation d'oligopeptides cycliques microbiologiques |
NZ590517A (en) * | 2008-07-30 | 2012-12-21 | Isotechnika Pharma Inc | Nonimmunosuppressive cyclosporine analogue molecules |
NZ596868A (en) * | 2009-06-02 | 2014-04-30 | Nikan Pharmaceuticals Llc | Antagonism of human formyl peptide receptor for treatment of disease |
AU2011342284C1 (en) | 2010-12-15 | 2017-07-13 | Contravir Pharmaceuticals, Inc. | Cyclosporine analogue molecules modified at amino acid 1 and 3 |
AR090964A1 (es) * | 2012-05-09 | 2014-12-17 | Novartis Ag | Proceso para la elaboracion de undecapeptidos ciclicos |
AR111963A1 (es) * | 2017-05-26 | 2019-09-04 | Univ California | Método y moléculas |
EP3765482A4 (fr) | 2018-04-13 | 2021-04-28 | National Institute Of Biological Sciences, Beijing | Inhibiteurs de ntcp |
CN110174363A (zh) * | 2019-01-09 | 2019-08-27 | 北京九强生物技术股份有限公司 | 6-磷酸葡萄糖脱氢酶突变体及其在制备检测试剂中的用途 |
CN113388002A (zh) * | 2021-06-10 | 2021-09-14 | 梯尔希(南京)药物研发有限公司 | 一种环孢菌素相关化合物的制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE95193T1 (de) * | 1987-06-17 | 1993-10-15 | Sandoz Ag | Cyclosporine und deren benutzung als arzneimittel. |
US5202310A (en) * | 1990-06-06 | 1993-04-13 | Levy Gary A | Cyclosporine metabolites |
US5834266A (en) * | 1993-02-12 | 1998-11-10 | President & Fellows Of Harvard College | Regulated apoptosis |
US5716928A (en) * | 1995-06-07 | 1998-02-10 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
NZ502362A (en) * | 1997-10-08 | 2001-05-25 | Isotechnika Inc | Deuterated cyclosporine A derivatives and their use as immunomodulating agents |
US6784156B2 (en) * | 2001-03-05 | 2004-08-31 | Enanta Pharmaceuticals, Inc. | Cyclosporins for the treatment of respiratory diseases |
EP1816138A1 (fr) * | 2001-10-19 | 2007-08-08 | Isotechnika,Inc. | Mélanges analogues de cyclosporine et leur utilisation en tant qu'agents immunomodulateurs |
WO2003033526A2 (fr) * | 2001-10-19 | 2003-04-24 | Isotechnika Inc. | Synthese d'analogues de cyclosporine |
US20040110666A1 (en) * | 2002-12-04 | 2004-06-10 | Or Yat Sun | Cyclosporins for the treatment of immune disorders |
US7012065B2 (en) * | 2003-02-07 | 2006-03-14 | Enanta Pharmaceuticals, Inc. | Cyclosporins for the treatment of immune disorders |
AU2004222306A1 (en) * | 2003-03-17 | 2004-09-30 | Albany Molecular Research, Inc. | Novel cyclosporins |
US20040266669A1 (en) * | 2003-06-20 | 2004-12-30 | Wu Frank X. H. | Cyclosporin derivatives for the treatment of immune disorders |
-
2005
- 2005-12-19 US US11/313,239 patent/US20060223743A1/en not_active Abandoned
- 2005-12-19 AU AU2005316095A patent/AU2005316095A1/en not_active Abandoned
- 2005-12-19 WO PCT/CA2005/001926 patent/WO2006063470A1/fr active Application Filing
- 2005-12-19 TW TW094144998A patent/TW200635954A/zh unknown
- 2005-12-19 KR KR1020077015724A patent/KR20070100284A/ko not_active Application Discontinuation
- 2005-12-19 MX MX2007007262A patent/MX2007007262A/es not_active Application Discontinuation
- 2005-12-19 CA CA002592343A patent/CA2592343A1/fr not_active Abandoned
- 2005-12-19 JP JP2007545805A patent/JP2008524122A/ja not_active Withdrawn
- 2005-12-19 CN CNA2005800481960A patent/CN101120012A/zh active Pending
- 2005-12-19 BR BRPI0517207-1A patent/BRPI0517207A/pt not_active IP Right Cessation
- 2005-12-19 EP EP05825030A patent/EP1828229A4/fr not_active Withdrawn
-
2007
- 2007-06-13 IL IL183908A patent/IL183908A0/en unknown
- 2007-06-14 TN TNP2007000225A patent/TNSN07225A1/fr unknown
- 2007-07-04 ZA ZA200705475A patent/ZA200705475B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1828229A1 (fr) | 2007-09-05 |
EP1828229A4 (fr) | 2010-06-30 |
WO2006063470A1 (fr) | 2006-06-22 |
CA2592343A1 (fr) | 2006-06-22 |
WO2006063470B1 (fr) | 2006-08-03 |
BRPI0517207A (pt) | 2008-09-30 |
TW200635954A (en) | 2006-10-16 |
IL183908A0 (en) | 2007-10-31 |
KR20070100284A (ko) | 2007-10-10 |
CN101120012A (zh) | 2008-02-06 |
ZA200705475B (en) | 2008-07-30 |
AU2005316095A1 (en) | 2006-06-22 |
US20060223743A1 (en) | 2006-10-05 |
JP2008524122A (ja) | 2008-07-10 |
MX2007007262A (es) | 2007-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200635954A (en) | Metabolites of cyclosporin analogs | |
Van Wagoner et al. | Polyketide biosynthesis in dinoflagellates: what makes it different? | |
Aly et al. | Fungal endophytes–secret producers of bioactive plant metabolites | |
Jensen et al. | The marine actinomycete genus Salinispora: a model organism for secondary metabolite discovery | |
Cragg et al. | Impact of natural products on developing new anti-cancer agents | |
Skropeta et al. | Recent advances in deep-sea natural products | |
König et al. | Natural products from marine organisms and their associated microbes | |
Cragg et al. | Nature: a vital source of leads for anticancer drug development | |
Bugni et al. | Marine-derived fungi: a chemically and biologically diverse group of microorganisms | |
Raja et al. | Phylogenetic and chemical diversity of fungal endophytes isolated from Silybum marianum (L) Gaertn.(milk thistle) | |
WO2006040763A3 (fr) | Lignees de cellules souches derivees de culture de blastocystes prolongee et leurs utilisations | |
SG149061A1 (en) | Definitive endoderm | |
Amna et al. | Effect of precursors feeding and media manipulation on production of novel anticancer pro-drug camptothecin from endophytic fungus | |
Mishra et al. | Exploiting endophytic microbes as micro-factories for plant secondary metabolite production | |
Uka et al. | Secondary metabolite dereplication and phylogenetic analysis identify various emerging mycotoxins and reveal the high intra-species diversity in Aspergillus flavus | |
Devine et al. | Future directions for the discovery of antibiotics from actinomycete bacteria | |
Ebel | 20 natural products from marine derived fungi | |
Liu et al. | Xyloketal H from the mangrove endophytic fungus Xylaria sp. 2508 | |
Orjala et al. | Discovery of potential anticancer agents from aquatic cyanobacteria, filamentous fungi, and tropical plants | |
WO2007031556A3 (fr) | Moyens et procedes permettant d'ameliorer la production de vinblastine et de vincristine dans catharanthus roseus | |
Zotchev | Alkaloids from marine bacteria | |
Giddings et al. | Bioactive compounds from extremophilic marine fungi | |
Cragg et al. | Natural products in drug discovery: recent advances | |
Wang et al. | Unraveling the chemical interactions of fungal endophytes for exploitation as microbial factories | |
Garyali et al. | Exploitation of Fungal Endophytes as Bio-Factories for Production of Functional Metabolites through Metabolic Engineering; Emphasizing on Taxol Production |